Results 11 to 20 of about 34 (34)

STATIN GENERICS: EFFICACY AND SAFETY RATIO

Рациональная фармакотерапия в кардиологии, 2016
Statin usage for primary and secondary prevention of cardiovascular diseases is focused. Rational choice between original and generic drugs is discussed taking into account efficacy and safety ratio.
V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova   +4 more
doaj   +1 more source

Norma i patologiya v tireoidologii: simpozium kompanii “Berlin-Khemi” na Vserossiyskom kongresse “Sovremennye tekhnologii v endokrinologii”

Клиническая и экспериментальная тиреоидология, 2009
Всероссийский конгресс “Современные технологии в эндокринологии” (тиреоидология, нейроэндокринология, эндокринная хирургия) состоялся в Москве 23–26 ноября 2009 г. На конгрессе обсуждались вопросы эпидемиологии, генетики, ранней диагностики, профилактики

doaj   +1 more source

Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance

Медицинский совет, 2013
The article reviews current approaches to primary prevention of cardiovascular events and risk-benefit balance in the use of statin therapy in healthy people at risk of cardiovascular disease; the results of large clinical trials evaluating the efficacy ...
S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuzmina   +2 more
doaj   +1 more source

PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM

Рациональная фармакотерапия в кардиологии, 2015
Aim. To estimate incidence rate of first myocardial infarction (MI) with different outcomes and factors, it is influenced by, depending on the intensity of preventive measures in a population of middle-aged men during 15-year follow-up; to evaluate ...
A. M. Kalinina, A. V. Kontsevaya
doaj   +1 more source

CHARACTERISTICS OF PATIENTS WITH CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK, INCLUDED INTO THE LIS-2 REGISTER (LYUBERTSY STUDY OF MORTALITY IN PATIENTS AFTER STROKE)

Рациональная фармакотерапия в кардиологии, 2015
Aim. To provide final data on the three-year period of the inclusion of patients; to give most accurate "portrait" of patients hospitalized with a brain stroke within the framework of the LIS-2 register (Lyubertsy study of mortality in patients after ...
S. Yu. Martsevich, N. P. Kutishenko1, A. Yu. Suvorov, M. L. Ginzburg, A. D. Deev, S. A. Boytsov, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina   +15 more
doaj   +1 more source

Evaluation of informativity risk factors of breast cancer in the female population of the Omsk region: Bayesian approach

Эпидемиология и вакцинопрофилактика, 2015
The paper shows the possibility of assessment of individual risk of developing breast cancer in women using an algorithm based on Bayes ' theorem. An epidemiological study (such as "case-control"), the prevalence of known risk factors for breast cancer ...
N. G. Shirlina, D. V. Turchaninov, V. L. Stasenko, E. A. Vilms   +3 more
doaj   +1 more source

PROSTAGLANDINS ANALOGUES DURING CATARACT PHACOEMULSIFICATION ON THE BACKGROUND OF PRIMARY GLAUCOMA

Acta Biomedica Scientifica, 2016
We analysed the effect of prostoglandins analogues application on the course of postoperative period of cataract phakoemulsification in 58 patients with primary open-angle glaucoma.
I. E. Ioshin, A. I. Tolchinskaya
doaj   +1 more source

Profilaktika postmenopauzal'nogo osteoporoza: rol' preparatov kal'tsiya i vitamina D

Гинекология, 2005
Остеопороз (ОП) – одно из наиболее распространенных заболеваний, которое занимает ведущее место в структуре заболеваемости и смертности населения. В клинических рекомендациях утверждается, что первичная профилактика постменопаузального ОП направлена на ...
N V Toroptsova
doaj  

COMORBIDITIES IN PRACTICE. CLINICAL GUIDELINES

Кардиоваскулярная терапия и профилактика, 2017
.
R. G. Oganov, I. N. Denisov, V. I. Simanenkov, I. G. Bakulin, N. V. Bakulina, S. A. Boldueva, O. N Barbarash, N. P Garganeeva, V. L Doshchitsin, O. M. Drapkina, E. N. Dudinskaya, Yu. V. Kotovskaya, A. M. Lila, M. N. Mamedov, B. U. Mardanov, O. N. Miller, M. M. Petrova, Yu. M. Pozdnyakov, N. K. Runikhina, S. A. Sayganov, A. V. Tarasov, O. N. Tkacheva, A. M. Urinsky, S. A. Shalnova   +23 more
doaj   +1 more source

Acetylsalicylic acid in primary and secondary prevention of cardiovascular diseases. Is it all obvious?

Медицинский совет, 2015
The review tells about the results of clinical trials and meta-analyses demonstrating the effectiveness of acetylsalicylic acid (ASA) for secondary prevention of cardiovascular diseases, namely, improved prognosis for patients after myocardial infarction
A. V. Panov, E. V. Kuleshova
doaj   +1 more source